Fischereder M - Search Results

1

Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis.

Andrassy J, Hoffmann VS, Rentsch M, Stangl M, Habicht A, Meiser B, Fischereder M, Jauch KW, Guba M. Andrassy J, et al. Among authors: fischereder m. Transplantation. 2012 Dec 27;94(12):1208-17. doi: 10.1097/TP.0b013e3182708e56. Transplantation. 2012. PMID: 23269449 Review.

2

Early graft failure with thrombophilia and effects of anticoagulation.

Fischereder M, Schneeberger H, Göhring P, Hillebrand G, Schlöndorff D, Land W. Fischereder M, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):360-1. doi: 10.1016/s0041-1345(98)01661-3. Transplant Proc. 1999. PMID: 10083142 Clinical Trial. No abstract available.

3

Gynaecomastia following solid organ transplantation.

Fischereder M, Gräb C, Anthuber M, Krüger B, Zülke C, Jauch KW, Krämer BK. Fischereder M, et al. Transplant Proc. 2002 Sep;34(6):2227-8. doi: 10.1016/s0041-1345(02)03214-1. Transplant Proc. 2002. PMID: 12270376 No abstract available.

4

Early experience with the ET Senior Program "Old For Old"; better to be number one?

Krüger B, Zülke C, Fischereder M, Leingärtner T, Kammerl M, Fürst A, Graeb C, Anthuber M, Jauch KW, Krämer BK. Krüger B, et al. Among authors: fischereder m. Transpl Int. 2002 Nov;15(11):541-5. doi: 10.1007/s00147-002-0439-4. Epub 2002 Oct 8. Transpl Int. 2002. PMID: 12461657

5

Etiology of cardiovascular diseases in the transplant population: will the choice of immunosuppressant matter?

Fischereder M, Land W. Fischereder M, et al. Transplant Proc. 2004 Sep;36(7):1993-4. doi: 10.1016/j.transproceed.2004.08.111. Transplant Proc. 2004. PMID: 15518721 Review. No abstract available.

6

Prevalence of cancer history prior to renal transplantation.

Fischereder M, Jauch KW. Fischereder M, et al. Transpl Int. 2005 Jul;18(7):779-84. doi: 10.1111/j.1432-2277.2005.00109.x. Transpl Int. 2005. PMID: 15948855 Free article.

7

Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy.

Hartmann B, Schmid G, Graeb C, Bruns CJ, Fischereder M, Jauch KW, Heeschen C, Guba M. Hartmann B, et al. Among authors: fischereder m. Kidney Int. 2005 Dec;68(6):2593-8. doi: 10.1111/j.1523-1755.2005.00731.x. Kidney Int. 2005. PMID: 16316335 Free article. Clinical Trial.

8

Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.

Fischereder M, Graeb C, Krüger B, Kammerl MC, Zülke C, Jauch KW, Krämer BK. Fischereder M, et al. Transplant Proc. 2006 Jun;38(5):1295-7. doi: 10.1016/j.transproceed.2006.03.026. Transplant Proc. 2006. PMID: 16797286

9

Effects of dietary factors on drug transport and metabolism: the impact on dosage guidelines in transplant patients.

Nowack R, Andrassy J, Fischereder M, Unger M. Nowack R, et al. Among authors: fischereder m. Clin Pharmacol Ther. 2009 Apr;85(4):439-43. doi: 10.1038/clpt.2008.303. Epub 2009 Feb 18. Clin Pharmacol Ther. 2009. PMID: 19225452 Review. No abstract available.

10

Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial.

Arbogast HP, Hoffmann JN, Illner WD, Hillebrand GF, Fischereder M, Jauch KW, Land W. Arbogast HP, et al. Among authors: fischereder m. Transplant Proc. 2009 Jul-Aug;41(6):2529-32. doi: 10.1016/j.transproceed.2009.06.151. Transplant Proc. 2009. PMID: 19715968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters